Abbott Architect Havab-M
Hepatitis A Test (Antibody And Igm Antibody). 510(k) K063329, from Abbott Laboratories (Abbott Park, IL). Product code LOL, class 2.
As of Nov 21, 2026, K063329 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on Apr 16, 2007 after 164 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 164 days
- Recalls: 2
- Cited as a predicate by: 2 devices
The ARCHITECT HAVAB-M assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of IgM antibody to hepatitis A virus (IgM anti-HAV) in human adult and pediatric serum and plasma (dipotassium EDTA, lithium heparin, and sodium heparin) and neonatal serum.
- Access anti-HAV IgMK251995 · Beckman Coulter, Inc. · Jan 27, 2026
- Architect Havab-GK113704 · Abbott Laboratories · Jun 28, 2012
| Apr 20, 2011 | Z-2413-2011The HAVAB-M reagent lot has reduced specificity and may cause an increase in false grayzone and/or false reactive results. | Terminated |
| Dec 30, 2009 | Z-1596-2010There is a potential to generate a false grayzone or reactive HAVAB-M result when the ARCHITECT AUSAB assay precedes the ARCHITECT HAVAB-M assay. | Terminated |
- Elecsys Anti-HAV IgMK260048 · Roche Diagnostics · Apr 7, 2026
- Access anti-HAV IgMK251995 · Beckman Coulter, Inc. · Jan 27, 2026
- Access anti-HAVK243846 · Beckman Coulter, Inc. · Sep 9, 2025
- HAVAb IgG IIK222850 · Abbott Laboratories · Aug 10, 2023
- LIAISON Anti-HAV; LIAISON XSK223403 · DiaSorin, Inc. · Dec 9, 2022
- LIAISON Anti-HAVK210272 · DiaSorin, Inc. · Feb 9, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Nov 3, 2006
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3310
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files